MHRA’s 2024–25 Annual Report and Accounts and Impact Report show progress on safety, innovation, and regulatory excellence

As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used

The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly.

Summary of the latest safety advice for medicines and medical device users

This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasing the risk of side effects.

LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing.

List of Field Safety Notices from 1 to 5 September 2025.